Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Return on Assets: 2020-2025

Historic Return on Assets for Keros Therapeutics (KROS) over the last 6 years, with Sep 2025 value amounting to 0.09%.

  • Keros Therapeutics' Return on Assets rose 45.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 45.00%. This contributed to the annual value of -0.38% for FY2024, which is 7.00% up from last year.
  • Keros Therapeutics' Return on Assets amounted to 0.09% in Q3 2025, which was up 252.87% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Keros Therapeutics' Return on Assets ranged from a high of 0.09% in Q3 2025 and a low of -0.49% during Q4 2023.
  • Its 3-year average for Return on Assets is -0.27%, with a median of -0.36% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first declined by 13bps in 2022, then skyrocketed by 45bps in 2025.
  • Keros Therapeutics' Return on Assets (Quarterly) stood at -0.24% in 2021, then fell by 13bps to -0.37% in 2022, then decreased by 11bps to -0.49% in 2023, then rose by 17bps to -0.31% in 2024, then soared by 45bps to 0.09% in 2025.
  • Its Return on Assets was 0.09% in Q3 2025, compared to 0.02% in Q2 2025 and 0.01% in Q1 2025.